Related Experiment Video
Updated: Jul 20, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Tianeptine can be effective in men with depression and erectile dysfunction
Hany El-Shafey1, Ahmad Atteya2, Samir Abu El-Magd3
1Department of Andrology, Sexology and STDs, Cairo University, Cairo, Egypt.
The Journal of Sexual Medicine
|September 1, 2006
Summary
Tianeptine effectively treated erectile dysfunction (ED) and depression in men. Significantly more patients responded to tianeptine compared to placebo, showing improved sexual function and mood.
Area of Science:
- Psychiatry
- Urology
- Pharmacology
Background:
- Erectile dysfunction (ED) and depression are common global health issues in men.
- Tianeptine is an antidepressant with a favorable sexual side effect profile.
Purpose of the Study:
- To assess tianeptine's effectiveness for treating mild to moderate depression accompanied by ED.
Main Methods:
- A randomized, double-blind, placebo-controlled, crossover trial.
- 68 patients received tianeptine or placebo for 8 weeks each.
- Assessments included validated questionnaires on depression, sexual function, and quality of life.
Main Results:
- Tianeptine significantly improved outcomes across all three assessment questionnaires compared to placebo (P < 0.05).
- 72.7% of patients responded to tianeptine, versus 27.9% responding to placebo.
- Treatment responders showed reduced depression, normal erectile function, and improved quality of life.
Conclusions:
- Tianeptine demonstrates efficacy in treating comorbid depression and ED.
- Further large-scale, multicenter studies are recommended to confirm these findings.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...